Prozac (Fluoxetine) is considered one of the most popular antidepressant medications of all time. It was developed by the pharmaceutical company Eli Lilly and approved for the treatment of major depression in 1987. Many people have had great success taking Prozac to manage depression, OCD, panic attacks, as well as eating disorders. The drug functions …
Most people are aware of the recent tragedy involving well-known actor and comedic legend Robin Williams. Although he was an extremely talented actor with a brilliant comedic talent, he commit suicide on August 11, 2014. This sent most of his close family members, friends, celebrities, and even the general public into shock. Most people were …
In recent years, biotech and pharmaceutical companies have been developing new classes of antidepressants. These new classes attempt to improve on older classes of medication in regards to efficacy, side effects, and tolerability. One such class that is being developed is that which targets opioid receptors, particularly the kappa receptor. These drugs are classified as …
Individuals diagnosed with major depression often are found to have reduced volume within their hippocampus. The hippocampus is a small region of the brain that is responsible for regulating various memory and spatial navigation functions. It is also believed to play a pivotal role in the regulation of mood. Modern day antidepressants such as SSRIs …
NRX-1074 is a new antidepressant under development by the biotech company Naurex. It is this same company that has already been granted “fast track” status by the FDA for their intravenous antidepressant GLYX-13 – which shows significant promise. Naurex’s private stock has been steadily rising due to emergence of preliminary evidence suggesting that both of …
A new antidepressant chemically named “GLYX-13” was developed by the biotech company Naurex for individuals with treatment-resistant depression. It is currently in clinical trials as an antidepressant augmentation strategy, meaning it is used as an add-on to already approved treatments. However, most evidence would suggest that it works extremely well as a standalone treatment option. …
For years, researchers have been investigating illicit drugs to determine whether they could be used under supervision to treat mental illnesses like depression and bipolar disorder. Although many of these substances have shown promise, in many cases the side effects and addiction potential outweigh any therapeutic benefits. Other times, many drugs may be temporarily helpful …